COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Treatment of Leishmaniasis With Impavido® (Miltefosine): Pregnancy Registry

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT02427308
Recruitment Status : Recruiting
First Posted : April 28, 2015
Last Update Posted : March 7, 2018
Information provided by (Responsible Party):
Knight Therapeutics (USA) Inc

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : March 2025
Estimated Study Completion Date : March 2026